• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Fisher & Paykel Healthcare Ltd Fisher and Paykel Healthcare; Nasal Cannula

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Fisher & Paykel Healthcare Ltd Fisher and Paykel Healthcare; Nasal Cannula Back to Search Results
Model Number OPT312
Medical Device Problem Code Material Split, Cut or Torn (4008)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/09/2026
Type of Reportable Event Malfunction
Event or Problem Description
A healthcare facility in china reported via the national medical products administration (nmpa) reporting system that the tubing of an opt312 optiflow junior infant nasal cannula was found to be broken at the connector end (swivel grip).There was no reported patient involvement.
 
Additional Manufacturer Narrative
(b)(4) section g4: no 510(k) number was included in section g4 of the report because the device is exempted from pma pathway to regulatory approval.Method: the subject device, opt312 optiflow junior nasal cannula was not returned to fisher & paykel healthcare (f&p) for evaluation.Our investigation is thus based on the information and photography provided by the healthcare facility, and our knowledge of the product.Results: upon evaluation of the provided photography, it was confirmed that one of the tubings was observed to be torn next to the connector end (swivel grip).Conclusion: we are unable to determine the exact cause of the reported event.As part of the manufacturing process, all optiflow junior cannulas are 100% leak and occlusion tested after final assembly and any cannula that fails specifications is discarded.In addition, representative samples from each batch are functionally tested to assess retention strength between the assembled components.If there are any failures the entire batch is quarantined for further investigation.The user instructions illustrate in pictorial format the correct set-up and proper use of the optiflow junior nasal cannula.They also state the following: - appropriate patient monitoring must be used at all times.Failure to monitor the patient may result in loss of therapy, serious injury or death.- do not stretch or crush tube.- ensure that all connections are secure during use.Check cannula is undamaged and that the flow path is maintained.Under excessive load, the cannula may disconnect to prevent forces being transferred to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Fisher and Paykel Healthcare
Common Device Name
Nasal Cannula
Manufacturer (Section D)
Fisher & Paykel Healthcare Ltd
15 maurice paykel place
east tamaki
auckland, 2013
NZ  2013
Manufacturer (Section G)
Fisher & Paykel Healthcare Ltd
15 maurice paykel place
east tamaki
auckland, 2013
NZ   2013
Manufacturer Contact
diego vargas banuelos
17400 laguna canyon road
suite 300
irvine, CA 92618
+1(949)434-1005
MDR Report Key50230743
Report Number9611451-2026-02433
Device Sequence Number10336163
Product Code CAT
UDI-Device Identifier09420012432278
UDI-Public(01)09420012432278(10)2103160129(11)240529(17)270529
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K162553
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 09/16/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberOPT312
Device Catalogue NumberOPT312
Device Lot Number2103160129
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/15/2026
Supplement Date Received by Manufacturer08/19/2026
Initial Report FDA Received Date08/13/2026
Supplement Report FDA Received Date09/16/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/29/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexMale
-
-